Argentina's Malbrán joins international post-marketing study of infant pneumococcal vaccine

Argentina's Malbrán Institute will participate in an international post-marketing surveillance study of a pneumococcal vaccine already in domestic use since last year under a three-dose schedule. The study aims to monitor real-world safety and effectiveness; details on scope and partners remain unspecified. This is a routine public-health research collaboration, not a market-moving event.